Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 39,000 | 145,000 | 31,000 | 32,000 | 29,000 |
| Gross Profit | 39,000 | 145,000 | 31,000 | 32,000 | 29,000 |
| Operating Expenses | 145,000 | 161,000 | 122,000 | 112,000 | 112,000 |
| Operating Income | -106,000 | -16,000 | -91,000 | -80,000 | -83,000 |
| Interest Expense | 0 | 1,000 | 1,000 | 1,000 | 0 |
| Other Income | 13,000 | 13,000 | 12,000 | 12,000 | 9,000 |
| Pre-tax Income | -93,000 | -4,000 | -80,000 | -69,000 | -74,000 |
| Income Tax | N/A | N/A | 1,000 | 2,000 | 1,000 |
| Net Income Continuous | -93,000 | -4,000 | -81,000 | -71,000 | -75,000 |
| Net Income | $-93,000 | $-4,000 | $-81,000 | $-71,000 | $-75,000 |
| EPS Basic Total Ops | -1.02 | -0.05 | -1.08 | -0.94 | -1.04 |
| EPS Basic Continuous Ops | -1.02 | -0.05 | -1.08 | -0.95 | -1.02 |
| EPS Diluted Total Ops | -1.02 | -0.05 | -1.08 | -0.94 | -1.04 |
| EPS Diluted Continuous Ops | -1.02 | -0.05 | -1.08 | -0.95 | -1.02 |
| EPS Diluted Before Non-Recurring Items | -1.02 | -0.05 | -1.08 | N/A | N/A |
| EBITDA(a) | $-111,000 | $-19,000 | $-94,000 | $-84,000 | $-85,000 |